These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 24719326

  • 1. Mortalin/GRP75 binds to complement C9 and plays a role in resistance to complement-dependent cytotoxicity.
    Saar Ray M, Moskovich O, Iosefson O, Fishelson Z.
    J Biol Chem; 2014 May 23; 289(21):15014-22. PubMed ID: 24719326
    [Abstract] [Full Text] [Related]

  • 2. Cooperation between Hsp90 and mortalin/GRP75 in resistance to cell death induced by complement C5b-9.
    Rozenberg P, Ziporen L, Gancz D, Saar-Ray M, Fishelson Z.
    Cell Death Dis; 2018 Feb 02; 9(2):150. PubMed ID: 29396434
    [Abstract] [Full Text] [Related]

  • 3. Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis.
    Pilzer D, Fishelson Z.
    Int Immunol; 2005 Sep 02; 17(9):1239-48. PubMed ID: 16091382
    [Abstract] [Full Text] [Related]

  • 4. Regulation of Complement-Dependent Cytotoxicity by MicroRNAs miR-200b, miR-200c, and miR-217.
    Hillman Y, Mazkereth N, Farberov L, Shomron N, Fishelson Z.
    J Immunol; 2016 Jun 15; 196(12):5156-65. PubMed ID: 27183614
    [Abstract] [Full Text] [Related]

  • 5. Complement triggers relocation of Mortalin/GRP75 from mitochondria to the plasma membrane.
    Mazkereth N, Rocca F, Schubert JR, Geisler C, Hillman Y, Egner A, Fishelson Z.
    Immunobiology; 2016 Dec 15; 221(12):1395-1406. PubMed ID: 27475989
    [Abstract] [Full Text] [Related]

  • 6. Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity.
    Pilzer D, Saar M, Koya K, Fishelson Z.
    Int J Cancer; 2010 Mar 15; 126(6):1428-35. PubMed ID: 19739077
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA, Zhao J, Ninomiya H, Sims PJ.
    J Immunol; 1991 Apr 01; 146(7):2345-51. PubMed ID: 1706395
    [Abstract] [Full Text] [Related]

  • 8. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L, Morris CA, Sheehan MC, Charlesworth JA, Pussell BA.
    Clin Exp Immunol; 1993 Apr 01; 92(1):114-9. PubMed ID: 7682159
    [Abstract] [Full Text] [Related]

  • 9. Quantification of complement C5b-9 binding to cells by flow cytometry.
    Moskovich O, Fishelson Z.
    Methods Mol Biol; 2014 Apr 01; 1100():103-8. PubMed ID: 24218253
    [Abstract] [Full Text] [Related]

  • 10. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
    Rollins SA, Sims PJ.
    J Immunol; 1990 May 01; 144(9):3478-83. PubMed ID: 1691760
    [Abstract] [Full Text] [Related]

  • 11. The killer molecule of complement.
    Müller-Eberhard HJ.
    J Invest Dermatol; 1985 Jul 01; 85(1 Suppl):47s-52s. PubMed ID: 3891882
    [Abstract] [Full Text] [Related]

  • 12. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
    Kontermann R, Deppisch R, Rauterberg EW.
    Eur J Immunol; 1990 Mar 01; 20(3):623-8. PubMed ID: 1690659
    [Abstract] [Full Text] [Related]

  • 13. Mortalin peptides exert antitumor activities and act as adjuvants to antibody-mediated complement-dependent cytotoxicity.
    Jubran R, Saar-Ray M, Wawruszak A, Ziporen L, Donin N, Bairey O, Fishelson Z.
    Int J Oncol; 2020 Oct 01; 57(4):1013-1026. PubMed ID: 32700755
    [Abstract] [Full Text] [Related]

  • 14. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
    Joiner KA, Tartanian AB, Hammer CH, Schweinle JE.
    J Immunol; 1989 Jun 15; 142(12):4450-7. PubMed ID: 2656866
    [Abstract] [Full Text] [Related]

  • 15. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER, Tschoop J, Müller-Eberhard HJ.
    J Exp Med; 1982 Jul 01; 156(1):268-82. PubMed ID: 6177822
    [Abstract] [Full Text] [Related]

  • 16. Hexamerization-enhanced CD20 antibody mediates complement-dependent cytotoxicity in serum genetically deficient in C9.
    Taylor RP, Lindorfer MA, Cook EM, Beurskens FJ, Schuurman J, Parren PWHI, Zent CS, VanDerMeid KR, Burack R, Mizuno M, Morgan BP.
    Clin Immunol; 2017 Aug 01; 181():24-28. PubMed ID: 28578024
    [Abstract] [Full Text] [Related]

  • 17. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ.
    Biochem Soc Symp; 1985 Aug 01; 50():235-46. PubMed ID: 2428370
    [Abstract] [Full Text] [Related]

  • 18. Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement.
    Zalman LS, Müller-Eberhard HJ.
    Mol Immunol; 1990 Jun 01; 27(6):533-7. PubMed ID: 1696352
    [Abstract] [Full Text] [Related]

  • 19. Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice.
    Fu X, Ju J, Lin Z, Xiao W, Li X, Zhuang B, Zhang T, Ma X, Li X, Ma C, Su W, Wang Y, Qin X, Liang S.
    Sci Rep; 2016 Jul 22; 6():30239. PubMed ID: 27444648
    [Abstract] [Full Text] [Related]

  • 20. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S, Tranum-Jensen J.
    J Immunol; 1986 Apr 15; 136(8):2999-3005. PubMed ID: 3958488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.